Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 28056202

Trastuzumab Emtansine With or Without Pertuzumab Versus Trastuzumab Plus Taxane for Human Epidermal Growth Factor Receptor 2-Positive, Advanced Breast Cancer: Primary Results From the Phase III MARIANNE Study.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
J Clin Oncol
Publication date
2017 Jan 10
First author
Perez EA

This record carries publication-notice metadata. Review the notices below before relying on it.

Publication notices

absence is not clearance
true
has correction metadata
true
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    J Clin Oncol. 2017 Jan 10;35(2):127-130. doi: 10.1200/JCO.2016.70.2712.
    note
    Source null
    related pmid
    27918726
    relationship
    Comment in
  2. citation
    J Clin Oncol. 2017 Jul 10;35(20):2342. doi: 10.1200/JCO.2017.74.3971.
    note
    Source null
    related pmid
    28679104
    relationship
    Erratum in
  3. citation
    J Clin Oncol. 2019 Feb 1;37(4):358. doi: 10.1200/JCO.18.02271.
    note
    Source null
    related pmid
    30695670
    relationship
    Erratum in

Authors and identifiers

  1. name
    Perez EA
    type
    Author
  2. name
    Barrios C
    type
    Author
  3. name
    Eiermann W
    type
    Author
  4. name
    Toi M
    type
    Author
  5. name
    Im YH
    type
    Author
  6. name
    Conte P
    type
    Author
  7. name
    Martin M
    type
    Author
  8. name
    Pienkowski T
    type
    Author
  9. name
    Pivot X
    type
    Author
  10. name
    Burris H 3rd
    type
    Author
  11. name
    Petersen JA
    type
    Author
  12. name
    Stanzel S
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Perez EA
    type
    Author
  2. name
    Barrios C
    type
    Author
  3. name
    Eiermann W
    type
    Author
  4. name
    Toi M
    type
    Author
  5. name
    Im YH
    type
    Author
  6. name
    Conte P
    type
    Author
  7. name
    Martin M
    type
    Author
  8. name
    Pienkowski T
    type
    Author
  9. name
    Pivot X
    type
    Author
  10. name
    Burris H 3rd
    type
    Author
  11. name
    Petersen JA
    type
    Author
  12. name
    Stanzel S
    type
    Author
bibliography ids
  1. nci-bib-011702a2638be7e9d4eadc9b
book metadata
content sha256
90c6a6161401f76bafccd5372fe875662448ed3460e481e2aaa04999ed72f446
document type
citation
dois
  1. 10.1200/JCO.2016.67.4887
electronic publication date
display
2016 Nov 7
precision
day
year
2016
evidence scope
bibliographic_metadata_only
id
pubmed:28056202
immutable id
pubmed:28056202@90c6a6161401f76bafccd5372fe875662448ed3460e481e2aaa04999ed72f446
journal
abbreviation
J Clin Oncol
issn electronic
1527-7755
issn print
0732-183X
issue
2
name
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
nlm unique id
8309333
pages
141-148
volume
35
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
true
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    J Clin Oncol. 2017 Jan 10;35(2):127-130. doi: 10.1200/JCO.2016.70.2712.
    note
    Source null
    related pmid
    27918726
    relationship
    Comment in
  2. citation
    J Clin Oncol. 2017 Jul 10;35(20):2342. doi: 10.1200/JCO.2017.74.3971.
    note
    Source null
    related pmid
    28679104
    relationship
    Erratum in
  3. citation
    J Clin Oncol. 2019 Feb 1;37(4):358. doi: 10.1200/JCO.18.02271.
    note
    Source null
    related pmid
    30695670
    relationship
    Erratum in
outcomes validated
false
pmid
28056202
provenance
batch id
7a1288ac8bb5f9826304
provider
NCBI PubMed ESummary
record sha256
fb6076b612909a08991e68750087ec68335ab963aba0fc5e9f5bd48efe8ad2bc
response sha256
0e879bec8c19d1cfda5629dca8745b04155d18cf54361825d4c070aebad2984d
retrieved at
2026-09-09T23:47:23.138359+00:00
publication date
display
2017 Jan 10
precision
day
year
2017
publication types
  1. Clinical Trial, Phase III
  2. Comparative Study
  3. Journal Article
  4. Randomized Controlled Trial
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/28056202/
title
Trastuzumab Emtansine With or Without Pertuzumab Versus Trastuzumab Plus Taxane for Human Epidermal Growth Factor Receptor 2-Positive, Advanced Breast Cancer: Primary Results From the Phase III MARIANNE Study.

Preserved source evidence · Not medical advice